Literature DB >> 15390262

Sequence-based prediction of pathological mutations.

C Ferrer-Costa1, M Orozco, X de la Cruz.   

Abstract

The development of methods to assess the impact of amino acid mutations on human health has become an important goal in biomedical research, due to the growing number of nonsynonymous SNPs identified. Within this context, computational methods constitute a valuable tool, because they can easily process large amounts of mutations and give useful, almost cost-free, information on their pathological character. In this paper we present a computational approach to the prediction of disease-associated amino acid mutations, using only sequence-based information (amino acid properties, evolutionary information, secondary structure and accessibility predictions, and database annotations) and neural networks, as a model building tool. Mutations are predicted to be either pathological or neutral. Our results show that the method has a good overall success rate, 83%, that can reach 95% when trained for specific proteins. The methodology is fast and flexible enough to provide good estimates of the pathological character of large sets of nonsynonymous SNPs, but can also be easily adapted to give more precise predictions for proteins of special biomedical interest. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15390262     DOI: 10.1002/prot.20252

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  79 in total

1.  Testing computational prediction of missense mutation phenotypes: functional characterization of 204 mutations of human cystathionine beta synthase.

Authors:  Qiong Wei; Liqun Wang; Qiang Wang; Warren D Kruger; Roland L Dunbrack
Journal:  Proteins       Date:  2010-07

2.  Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition.

Authors:  Laura B Ramsey; Gitte H Bruun; Wenjian Yang; Lisa R Treviño; Selina Vattathil; Paul Scheet; Cheng Cheng; Gary L Rosner; Kathleen M Giacomini; Yiping Fan; Alex Sparreboom; Torben S Mikkelsen; Thomas J Corydon; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Genome Res       Date:  2011-12-06       Impact factor: 9.043

3.  Searching for new genetic variations in expression databases for the GABAergic and glutamatergic systems.

Authors:  Manuela Barbosa Rodrigues de Souza; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2012-04-22       Impact factor: 3.444

4.  Adaptive clustering and adaptive weighting methods to detect disease associated rare variants.

Authors:  Qiuying Sha; Shuaicheng Wang; Shuanglin Zhang
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

5.  Sequence-based prioritization of nonsynonymous single-nucleotide polymorphisms for the study of disease mutations.

Authors:  Rui Jiang; Hua Yang; Linqi Zhou; C-C Jay Kuo; Fengzhu Sun; Ting Chen
Journal:  Am J Hum Genet       Date:  2007-06-22       Impact factor: 11.025

6.  Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools.

Authors:  Yong Zhu; Aaron Hoffman; Xifeng Wu; Heping Zhang; Yawei Zhang; Derek Leaderer; Tongzhang Zheng
Journal:  Mutat Res       Date:  2007-11-26       Impact factor: 2.433

7.  In silico analysis of missense substitutions using sequence-alignment based methods.

Authors:  Sean V Tavtigian; Marc S Greenblatt; Fabienne Lesueur; Graham B Byrnes
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

8.  Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.

Authors:  Francois Gros-Louis; Peter M Andersen; Nicolas Dupre; Makoto Urushitani; Patrick Dion; Frederique Souchon; Monique D'Amour; William Camu; Vincent Meininger; Jean-Pierre Bouchard; Guy A Rouleau; Jean-Pierre Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

9.  Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications.

Authors:  Sean V Tavtigian; Graham B Byrnes; David E Goldgar; Alun Thomas
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

10.  A family with spinocerebellar ataxia type 5 found to have a novel missense mutation within a SPTBN2 spectrin repeat.

Authors:  Ellen Cho; Brent L Fogel
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.